Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate
Ginny Ching-Yun Hsu, Yiyun Wang, Amy Z. Lu, Mario A. Gomez-Salazar, Jiajia Xu, Dongqing Li, Carolyn Meyers, Stefano Negri, Sintawat Wangsiricharoen, Kristen Broderick, Bruno Peault, Carol Morris, Aaron W. James
Ginny Ching-Yun Hsu, Yiyun Wang, Amy Z. Lu, Mario A. Gomez-Salazar, Jiajia Xu, Dongqing Li, Carolyn Meyers, Stefano Negri, Sintawat Wangsiricharoen, Kristen Broderick, Bruno Peault, Carol Morris, Aaron W. James
View: Text | PDF
Research Article Bone biology Cell biology

TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate

  • Text
  • PDF
Abstract

Pericytes are multipotent mesenchymal precursor cells that demonstrate tissue-specific properties. In this study, by comparing human adipose tissue– and periosteum-derived pericyte microarrays, we identified T cell lymphoma invasion and metastasis 1 (TIAM1) as a key regulator of cell morphology and differentiation decisions. TIAM1 represented a tissue-specific determinant between predispositions for adipocytic versus osteoblastic differentiation in human adipose tissue–derived pericytes. TIAM1 overexpression promoted an adipogenic phenotype, whereas its downregulation amplified osteogenic differentiation. These results were replicated in vivo, in which TIAM1 misexpression altered bone or adipose tissue generation in an intramuscular xenograft animal model. Changes in pericyte differentiation potential induced by TIAM1 misexpression correlated with actin organization and altered cytoskeletal morphology. Small molecule inhibitors of either small GTPase Rac1 or RhoA/ROCK signaling reversed TIAM1-induced morphology and differentiation in pericytes. In summary, our results demonstrate that TIAM1 regulates the cellular morphology and differentiation potential of human pericytes, representing a molecular switch between osteogenic and adipogenic cell fates.

Authors

Ginny Ching-Yun Hsu, Yiyun Wang, Amy Z. Lu, Mario A. Gomez-Salazar, Jiajia Xu, Dongqing Li, Carolyn Meyers, Stefano Negri, Sintawat Wangsiricharoen, Kristen Broderick, Bruno Peault, Carol Morris, Aaron W. James

×

Figure 5

Rac1 and ROCK inhibitors alter pericyte morphology and osteo/adipogenic differentiation potential with TIAM1 misexpression.

Options: View larger image (or click on image) Download as PowerPoint
Rac1 and ROCK inhibitors alter pericyte morphology and osteo/adipogenic ...
(A and B) Pericyte morphology after 48 hours of treatment with NSC23766 (Rac1 inhibitor, 5 μM) or Y27632 (ROCK inhibitor, 10 μM). F-actin appears green and DAPI staining appears blue. Images shown of human pericytes with TIAM1-KD or scramble siRNA. (C) Osteogenic gene markers at day 7 of osteogenic differentiation among TIAM1-KD or siRNA control–treated pericytes with NSC23766 or Y27632, as assessed by qRT-PCR. ALPL, alkaline phosphatase; BGLAP, osteocalcin; SP7, osterix. (D and E) Alizarin red staining and quantification on day 10 of osteogenic differentiation. (F and G) Pericyte morphology with treatment of NSC23766 (5 μM) or Y27632 (10 μM). F-actin appears green and DAPI staining appears blue. Images shown of human pericytes with TIAM1 OE or vector control. (H) Adipogenic gene marker expression at day 7 of adipogenic differentiation among TIAM1 OE or vector control–treated pericytes with NSC23766 or Y27632, as assessed by qRT-PCR. CEBPA, CCAAT enhancer binding protein alpha; FABP4, fatty acid-binding protein 4; ND, not determined; PPARG, peroxisome proliferator–activated receptor gamma. (I and J) Oil Red O staining and quantification on day 10. Representative images shown at 10× original magnification. *P < 0.05; **P < 0.01; ***P < 0.005 between the groups. #P < 0.05 in comparison with the corresponding treatment group with siScramble/pCMV control. Each dot in the scatterplots represents an individual well. Statistical analysis was performed using a 2-way ANOVA followed by Tukey’s post hoc test. White scale bars (A, B, F, and G): 20 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts